Bladder cancer study aims to end treatment guesswork

NCT ID NCT07225127

Recruiting now Knowledge-focused Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study looks at two common treatments for a type of bladder cancer that keeps coming back: treatments that keep the bladder (like medicine placed directly into the bladder) versus surgery to remove the bladder. The goal is to see which option is better for patients' wallets, daily life, and overall health. About 408 adults with high-grade non-muscle-invasive bladder cancer will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms urinary bladder cancer urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) RECURRENT BLADDER CANCER

Contacts and locations

Locations

Fred Hutch/University of Washington Cancer Consortium
RECRUITING

Seattle, Washington, 98195, United States
H. Lee Moffitt Cancer Center & Research Institute
RECRUITING

Tampa, Florida, 33612, United States
The Ohio State University
RECRUITING

Columbus, Ohio, 43210, United States
University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States
University of North Carolina
RECRUITING

Chapel Hill, North Carolina, 27599, United States
Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.